...
auph-img

Aurinia Pharmaceuticals Inc, Common Stock

AUPH

NMQ

$9.37

-$0.32

(-3.3%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.45B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.27M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.46
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.71 L
$10.67 H
$9.37

About Aurinia Pharmaceuticals Inc, Common Stock

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameAUPHSectorS&P500
1-Week Return4.93%-2.27%-0.57%
1-Month Return13.16%-3.96%1.21%
3-Month Return33.29%-9.7%7.57%
6-Month Return75.14%-3.37%11.45%
1-Year Return7.09%3.71%28.48%
3-Year Return-52.91%3.8%29.52%
5-Year Return-49.3%39.78%90.66%
10-Year Return151.21%106.91%203.75%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue318.00K50.12M45.60M134.03M175.51M[{"date":"2019-12-31","value":0.18,"profit":true},{"date":"2020-12-31","value":28.56,"profit":true},{"date":"2021-12-31","value":25.98,"profit":true},{"date":"2022-12-31","value":76.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue52.87M50.33M1.09M5.66M14.15M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":95.2,"profit":true},{"date":"2021-12-31","value":2.06,"profit":true},{"date":"2022-12-31","value":10.71,"profit":true},{"date":"2023-12-31","value":26.76,"profit":true}]
Gross Profit(52.55M)(209.00K)44.51M128.37M161.37M[{"date":"2019-12-31","value":-32.56,"profit":false},{"date":"2020-12-31","value":-0.13,"profit":false},{"date":"2021-12-31","value":27.59,"profit":true},{"date":"2022-12-31","value":79.55,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin(16524.53%)(0.42%)97.61%95.77%91.94%[{"date":"2019-12-31","value":-16929.53,"profit":false},{"date":"2020-12-31","value":-0.43,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.12,"profit":true},{"date":"2023-12-31","value":94.19,"profit":true}]
Operating Expenses76.57M147.60M225.25M239.84M253.06M[{"date":"2019-12-31","value":30.26,"profit":true},{"date":"2020-12-31","value":58.33,"profit":true},{"date":"2021-12-31","value":89.01,"profit":true},{"date":"2022-12-31","value":94.78,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(82.54M)(104.29M)(180.74M)(111.47M)(91.69M)[{"date":"2019-12-31","value":-8253900000,"profit":false},{"date":"2020-12-31","value":-10429000000,"profit":false},{"date":"2021-12-31","value":-18073500000,"profit":false},{"date":"2022-12-31","value":-11147000000,"profit":false},{"date":"2023-12-31","value":-9169100000,"profit":false}]
Total Non-Operating Income/Expense(38.50M)3.03M1.06M10.24M28.09M[{"date":"2019-12-31","value":-137.04,"profit":false},{"date":"2020-12-31","value":10.79,"profit":true},{"date":"2021-12-31","value":3.77,"profit":true},{"date":"2022-12-31","value":36.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(123.70M)(102.77M)(180.21M)(106.35M)(77.47M)[{"date":"2019-12-31","value":-12370200000,"profit":false},{"date":"2020-12-31","value":-10277400000,"profit":false},{"date":"2021-12-31","value":-18020600000,"profit":false},{"date":"2022-12-31","value":-10635200000,"profit":false},{"date":"2023-12-31","value":-7746900000,"profit":false}]
Income Taxes144.00K(94.00K)760.00K1.83M551.00K[{"date":"2019-12-31","value":7.88,"profit":true},{"date":"2020-12-31","value":-5.14,"profit":false},{"date":"2021-12-31","value":41.58,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":30.14,"profit":true}]
Income After Taxes(123.85M)(102.68M)(180.97M)(108.18M)(78.02M)[{"date":"2019-12-31","value":-12384600000,"profit":false},{"date":"2020-12-31","value":-10268000000,"profit":false},{"date":"2021-12-31","value":-18096600000,"profit":false},{"date":"2022-12-31","value":-10818000000,"profit":false},{"date":"2023-12-31","value":-7802000000,"profit":false}]
Income From Continuous Operations(123.85M)(102.68M)(180.97M)(108.18M)(77.19M)[{"date":"2019-12-31","value":-12384600000,"profit":false},{"date":"2020-12-31","value":-10268000000,"profit":false},{"date":"2021-12-31","value":-18096600000,"profit":false},{"date":"2022-12-31","value":-10818000000,"profit":false},{"date":"2023-12-31","value":-7719100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(123.85M)(102.68M)(180.97M)(108.18M)(78.02M)[{"date":"2019-12-31","value":-12384600000,"profit":false},{"date":"2020-12-31","value":-10268000000,"profit":false},{"date":"2021-12-31","value":-18096600000,"profit":false},{"date":"2022-12-31","value":-10818000000,"profit":false},{"date":"2023-12-31","value":-7802000000,"profit":false}]
EPS (Diluted)(1.30)(0.74)(1.41)(0.76)(0.54)[{"date":"2019-12-31","value":-130,"profit":false},{"date":"2020-12-31","value":-74,"profit":false},{"date":"2021-12-31","value":-141,"profit":false},{"date":"2022-12-31","value":-76,"profit":false},{"date":"2023-12-31","value":-54,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AUPH
Cash Ratio 4.44
Current Ratio 5.60
Quick Ratio 5.11

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AUPH
ROA (LTM) -2.16%
ROE (LTM) -5.78%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AUPH
Debt Ratio Lower is generally better. Negative is bad. 0.29
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.71

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AUPH
Trailing PE NM
Forward PE 13.74
P/S (TTM) 6.09
P/B 3.46
Price/FCF 79
EV/R 4.90
EV/Ebitda 246.17
PEG NM

FAQs

What is Aurinia Pharmaceuticals Inc share price today?

Aurinia Pharmaceuticals Inc (AUPH) share price today is $9.37

Can Indians buy Aurinia Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Aurinia Pharmaceuticals Inc (AUPH) on Vested. To buy Aurinia Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AUPH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Aurinia Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Aurinia Pharmaceuticals Inc (AUPH) via the Vested app. You can start investing in Aurinia Pharmaceuticals Inc (AUPH) with a minimum investment of $1.

How to invest in Aurinia Pharmaceuticals Inc shares from India?

You can invest in shares of Aurinia Pharmaceuticals Inc (AUPH) via Vested in three simple steps:

  • Click on Sign Up or Invest in AUPH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Aurinia Pharmaceuticals Inc shares
What is Aurinia Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Aurinia Pharmaceuticals Inc (AUPH) is $10.67. The 52-week low price of Aurinia Pharmaceuticals Inc (AUPH) is $4.71.

What is Aurinia Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Aurinia Pharmaceuticals Inc (AUPH) is

What is Aurinia Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Aurinia Pharmaceuticals Inc (AUPH) is 3.46

What is Aurinia Pharmaceuticals Inc dividend yield?

The dividend yield of Aurinia Pharmaceuticals Inc (AUPH) is 0.00%

What is the Market Cap of Aurinia Pharmaceuticals Inc?

The market capitalization of Aurinia Pharmaceuticals Inc (AUPH) is $1.45B

What is Aurinia Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Aurinia Pharmaceuticals Inc is AUPH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top